Drobnjak Nes, D.; Berg-Hansen, P.; de Rodez Benavent, S.A.; Høgestøl, E.A.; Beyer, M.K.; Rinker, D.A.; Veiby, N.; Karabeg, M.; Petrovski, B.É.; Celius, E.G.;
et al. Exploring Retinal Blood Vessel Diameters as Biomarkers in Multiple Sclerosis. J. Clin. Med. 2022, 11, 3109.
https://doi.org/10.3390/jcm11113109
AMA Style
Drobnjak Nes D, Berg-Hansen P, de Rodez Benavent SA, Høgestøl EA, Beyer MK, Rinker DA, Veiby N, Karabeg M, Petrovski BÉ, Celius EG,
et al. Exploring Retinal Blood Vessel Diameters as Biomarkers in Multiple Sclerosis. Journal of Clinical Medicine. 2022; 11(11):3109.
https://doi.org/10.3390/jcm11113109
Chicago/Turabian Style
Drobnjak Nes, Dragana, Pål Berg-Hansen, Sigrid A. de Rodez Benavent, Einar A. Høgestøl, Mona K. Beyer, Daniel A. Rinker, Nina Veiby, Mia Karabeg, Beáta Éva Petrovski, Elisabeth G. Celius,
and et al. 2022. "Exploring Retinal Blood Vessel Diameters as Biomarkers in Multiple Sclerosis" Journal of Clinical Medicine 11, no. 11: 3109.
https://doi.org/10.3390/jcm11113109
APA Style
Drobnjak Nes, D., Berg-Hansen, P., de Rodez Benavent, S. A., Høgestøl, E. A., Beyer, M. K., Rinker, D. A., Veiby, N., Karabeg, M., Petrovski, B. É., Celius, E. G., Harbo, H. F., & Petrovski, G.
(2022). Exploring Retinal Blood Vessel Diameters as Biomarkers in Multiple Sclerosis. Journal of Clinical Medicine, 11(11), 3109.
https://doi.org/10.3390/jcm11113109